Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$351,249.97
% of Total Estimate Gain
32.36%

Series A (StylePlus-Large Core Series)'s Vertex Pharmaceuticals Inc Holding Summary

As of 2024-09-30, Series A (StylePlus-Large Core Series) held - shares of Vertex Pharmaceuticals Inc(VRTX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Series A (StylePlus-Large Core Series) now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.

The initial trade took place in 2021Q4. And since then Series A (StylePlus-Large Core Series) has made 5 purchases of VRTX, at an average price of $281.71, for a total of 3,853.00 shares. In addition, there have been 7 sales at an average price of $372.87 for 3,853.00 shares. Based on historical transaction data and VRTX's current price of $445.82, Series A (StylePlus-Large Core Series)'s estimated gain on his VRTX holdings is $351,249.97, reflecting a 32.36% gain to date.

Series A (StylePlus-Large Core Series) VRTX ($445.82) Holding Chart

Series A (StylePlus-Large Core Series) VRTX ($445.82) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1